其他
$Inflection Point(IPAX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000086 Act: 34 Size: 3 KB 网页链接
· 此次II期临床研究IPAX-Linz正与TLX101的一项海外I期临床研究IPAX-2同时进行;
· 本集团核药抗肿瘤诊疗板块目前已储备13款创新产品,涵盖6种核素,覆盖8个癌种。
近日,$远大医药(00512)$ 与RD...查看全文
$Inflection Point(IPAX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000086 Act: 34 Size: 3 KB 网页链接
$Inflection Point(IPAX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001085146-23-001000 Act: 34 Size: 74 KB 网页链接
$Inflection Point(IPAX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001213900-23-009994 Act: 34 Size: 462 KB 网页链接
$Inflection Point(IPAX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-23-009998 Act: 34 Size: 184 KB 网页链接
$Inflection Point(IPAX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001393825-23-000117 Act: 34 Size: 58 KB 网页链接
$Inflection Point(IPAX)$ 8-K Current report, item 5.07 Accession Number: 0001213900-23-009374 Act: 34 Size: 323 KB 网页链接
$Inflection Point(IPAX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-23-008698 Act: 34 Size: 39 KB 网页链接
$Inflection Point(IPAX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001175707-23-000021 Act: 34 Size: 412 KB 网页链接
$Inflection Point(IPAX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-23-005139 Act: 34 Size: 25 KB 网页链接
$Inflection Point(IPAX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-23-005140 Act: 34 Size: 55 KB 网页链接